In-House Chip Fabrication & CBER Custom Solutions

The In-House Chip Fabrication and CBER Custom Solutions forecast, managed by the Food and Drug Administration, focuses on the procurement of raw materials such as plastics and PDMS to design and fabricate custom chips. This initiative is designed to develop bespoke systems tailored to the specific regulatory requirements of various CBER labs, filling critical gaps that standard off-the-shelf platforms cannot address. By providing these specialized fabrication capabilities, the contract establishes a unique and cost-effective resource available across the Center. The project falls under NAICS code 334413 and is coordinated through the CBER Acquisition Liaison to ensure that custom technical solutions are integrated effectively into agency operations.